TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS Trademark

Trademark Overview

On Wednesday, October 21, 2015, a trademark application was filed for TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS trademark a serial number of 86794366. The federal status of this trademark filing is REGISTERED as of Tuesday, November 27, 2018. This trademark is owned by Transformative Pharmaceutical Solutions, LLC. The TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS trademark is filed in the Advertising, Business and Retail Services category with the following description:

clinical research site management and monitoring, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; employment staffing in the field of clinical trials; business information management; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business project ma...
transformative pharmaceutical solutions

General Information

Serial Number86794366
Word MarkTRANSFORMATIVE PHARMACEUTICAL SOLUTIONS
Filing DateWednesday, October 21, 2015
Status700 - REGISTERED
Status DateTuesday, November 27, 2018
Registration Number5617769
Registration DateTuesday, November 27, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Goods and Servicesclinical research site management and monitoring, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; employment staffing in the field of clinical trials; business information management; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business project management in the field of clinical trials; providing the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials
Disclaimer with Predetermined Text"PHARMACEUTICAL SOLUTIONS"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, October 26, 2015
Primary Code035
First Use Anywhere DateWednesday, August 31, 2016
First Use In Commerce DateWednesday, August 31, 2016

Trademark Owner History

Party NameTransformative Pharmaceutical Solutions, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBlue Bell, PA 19422
Party NameTransformative Pharmaceutical Solutions, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBlue Bell, PA 19422
Party NameTransformative Pharmaceutical Solutions, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBlue Bell, PA 19422

Trademark Events

Event DateEvent Description
Monday, November 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 27, 2018REGISTERED-PRINCIPAL REGISTER
Friday, October 26, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 25, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 25, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, October 1, 2018USE AMENDMENT FILED
Thursday, October 25, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 1, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, March 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 13, 2018SOU EXTENSION 1 GRANTED
Tuesday, March 13, 2018SOU EXTENSION 1 FILED
Tuesday, March 13, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 18, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 18, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 22, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, February 16, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 16, 2017LETTER OF SUSPENSION E-MAILED
Thursday, February 16, 2017SUSPENSION LETTER WRITTEN
Wednesday, February 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 8, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 16, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 16, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 16, 2016LETTER OF SUSPENSION E-MAILED
Thursday, June 16, 2016SUSPENSION LETTER WRITTEN
Thursday, June 9, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 9, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 2, 2016ASSIGNED TO LIE
Friday, May 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 19, 2016NON-FINAL ACTION E-MAILED
Friday, February 19, 2016NON-FINAL ACTION WRITTEN
Thursday, February 11, 2016ASSIGNED TO EXAMINER
Monday, October 26, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 24, 2015NEW APPLICATION ENTERED

Related Keywords

solutions pharmaceutical transformative clinical business trial trials management investigators namely site research field